Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2007

Open Access 01-12-2007 | Review

Osteosarcoma (Osteogenic sarcoma)

Author: Piero Picci

Published in: Orphanet Journal of Rare Diseases | Issue 1/2007

Login to get access

Abstract

Osteosarcoma is a primary malignant tumour of the skeleton characterised by the direct formation of immature bone or osteoid tissue by the tumour cells. The classic osteosarcoma is a rare (0.2% of all malignant tumours) highly malignant tumour, with an estimated incidence of 3 cases/million population/year. Osteosarcoma arises predominantly in the long bones and rarely in the soft tissues. The age at presentation ranges from 10 to 25 years of age. Plain radiographs, computed tomography, magnetic resonance imaging, angiography and dynamic bone scintigraphy are used for diagnosis, evaluation the extent of tumour involvement and decision of the type of operation and, if necessary, the type of reconstruction. Years ago, all patients with osteosarcoma were treated by amputation but the cure rate was under 10% and almost all patients died within a year from diagnosis. Today, for localised osteosarcoma at onset (80% of cases) treated in specialized bone tumour centres with pre- and postoperative chemotherapy associated with surgery, the percentage of patients cured varies between 60% and 70%. Surgery is conservative (limb salvage) in more than 90% of patients. Prognosis is more severe (cure rate about 30%) for tumours located in the axial skeleton and in patients with metastasis at onset.
Literature
1.
go back to reference Schajowicz F, Sissons HA, Sobin LH: The World Health Organization's histologic classification of bone tumors. A commentary on the second edition. Cancer. 1995, 75 (5): 1208-1214. 10.1002/1097-0142(19950301)75:5<1208::AID-CNCR2820750522>3.0.CO;2-F.CrossRefPubMed Schajowicz F, Sissons HA, Sobin LH: The World Health Organization's histologic classification of bone tumors. A commentary on the second edition. Cancer. 1995, 75 (5): 1208-1214. 10.1002/1097-0142(19950301)75:5<1208::AID-CNCR2820750522>3.0.CO;2-F.CrossRefPubMed
2.
go back to reference Wolf RE, Enneking WF: The staging and surgery of musculoskeletal neoplasms. Orthop Clin North Am. 1996, 27 (3): 473-481.PubMed Wolf RE, Enneking WF: The staging and surgery of musculoskeletal neoplasms. Orthop Clin North Am. 1996, 27 (3): 473-481.PubMed
3.
go back to reference Campanacci M: Bone and Soft Tissue Tumors: Clinical Features, Imaging, Pathology and Treatment 2nd edition. Wien, Austria: Springer-Verlag; 1999:464-491.CrossRef Campanacci M: Bone and Soft Tissue Tumors: Clinical Features, Imaging, Pathology and Treatment 2nd edition. Wien, Austria: Springer-Verlag; 1999:464-491.CrossRef
4.
go back to reference Finkel MP, Reilly CA, Biskis BO: Pathogenesis of radiation and virus-induced bone tumors. Recent Results Cancer Res. 1976, 92-103. Finkel MP, Reilly CA, Biskis BO: Pathogenesis of radiation and virus-induced bone tumors. Recent Results Cancer Res. 1976, 92-103.
5.
go back to reference Swaney JJ: Familial osteogenic sarcoma. Clin Orthop Relat Res. 1973, 64-68. 10.1097/00003086-197311000-00010. 97CrossRefPubMed Swaney JJ: Familial osteogenic sarcoma. Clin Orthop Relat Res. 1973, 64-68. 10.1097/00003086-197311000-00010. 97CrossRefPubMed
6.
go back to reference Huvos AG: Bone Tumors: Diagnosis. Treatment and Prognosis 2nd edition. Philadelphia, W.B. Saunders. Co; 1991. Huvos AG: Bone Tumors: Diagnosis. Treatment and Prognosis 2nd edition. Philadelphia, W.B. Saunders. Co; 1991.
7.
go back to reference McIntyre JF, Smith-Sorensen B, Friend SH, Kassell J, Borresen AL, Yan YX, Russo C, Sato J, Barbier N, Miser J: Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol. 1994, 12 (5): 925-930.PubMed McIntyre JF, Smith-Sorensen B, Friend SH, Kassell J, Borresen AL, Yan YX, Russo C, Sato J, Barbier N, Miser J: Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol. 1994, 12 (5): 925-930.PubMed
8.
go back to reference Mirra JM: Bone Tumors: Clinical, Radiologic and Pathologic Correlations Philadelphia, Lea & Febiger; 1989:248-316. Mirra JM: Bone Tumors: Clinical, Radiologic and Pathologic Correlations Philadelphia, Lea & Febiger; 1989:248-316.
9.
go back to reference Abramson DH, Ellsworth RM, Zimmerman LE: Nonocular cancer in retinoblastoma survivors. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976, 81 (3 Pt 1): 454-457.PubMed Abramson DH, Ellsworth RM, Zimmerman LE: Nonocular cancer in retinoblastoma survivors. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976, 81 (3 Pt 1): 454-457.PubMed
10.
go back to reference Grimer RJ, Taminiau AM, Cannon SR: Surgical Subcommitte on behalf of the European Osteosarcoma Intergroup. Surgical outcomes in osteosarcoma. J Bone Joint Surg Br. 2002, 84 (3): 395-400. 10.1302/0301-620X.84B3.12019.CrossRefPubMed Grimer RJ, Taminiau AM, Cannon SR: Surgical Subcommitte on behalf of the European Osteosarcoma Intergroup. Surgical outcomes in osteosarcoma. J Bone Joint Surg Br. 2002, 84 (3): 395-400. 10.1302/0301-620X.84B3.12019.CrossRefPubMed
11.
go back to reference Bacci G, Ferrari S, Lari S, Mercuri M, Donati D, Longhi A, Forni C, Bertoni F, Versari M, Pignotti E: Osteosarcoma of thelimb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg Br. 2002, 84 (1): 88-92. 10.1302/0301-620X.84B1.12211.CrossRefPubMed Bacci G, Ferrari S, Lari S, Mercuri M, Donati D, Longhi A, Forni C, Bertoni F, Versari M, Pignotti E: Osteosarcoma of thelimb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg Br. 2002, 84 (1): 88-92. 10.1302/0301-620X.84B1.12211.CrossRefPubMed
12.
go back to reference Weeden S, Grimer RJ, Cannon SR, Taminiau AH, Uscinska BM: European Osteosarcoma Intergroup. The effect of local recurrence on survival in resected osteosarcoma. Eur J Cancer. 2001, 37 (1): 39-46. 10.1016/S0959-8049(00)00362-2.CrossRefPubMed Weeden S, Grimer RJ, Cannon SR, Taminiau AH, Uscinska BM: European Osteosarcoma Intergroup. The effect of local recurrence on survival in resected osteosarcoma. Eur J Cancer. 2001, 37 (1): 39-46. 10.1016/S0959-8049(00)00362-2.CrossRefPubMed
13.
go back to reference Picci P, Vanel D, Briccoli A, Talle K, Haakenaasen U, Malaguti C, Monti C, Ferrari C, Bacci G, Saeter G, Alvegard TA: Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation. Ann Oncol. 2001, 12 (11): 1601-1604. 10.1023/A:1013103511633.CrossRefPubMed Picci P, Vanel D, Briccoli A, Talle K, Haakenaasen U, Malaguti C, Monti C, Ferrari C, Bacci G, Saeter G, Alvegard TA: Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation. Ann Oncol. 2001, 12 (11): 1601-1604. 10.1023/A:1013103511633.CrossRefPubMed
14.
go back to reference Bacci G, Briccoli A, Rocca M, Ferrari S, Donati D, Longhi A, Bertoni F, Bacchini P, Giacomini S, Forni C, Manfrini M, Galletti S: Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide. Ann Oncol. 2003, 14 (7): 1126-1134. 10.1093/annonc/mdg286.CrossRefPubMed Bacci G, Briccoli A, Rocca M, Ferrari S, Donati D, Longhi A, Bertoni F, Bacchini P, Giacomini S, Forni C, Manfrini M, Galletti S: Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide. Ann Oncol. 2003, 14 (7): 1126-1134. 10.1093/annonc/mdg286.CrossRefPubMed
15.
go back to reference Kager L, Zoubek A, Potschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jurgens H, Gadner H, Bielack SS: Cooperative German-Austrian-Swiss Osteosarcoma Study Group. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2003, 21 (10): 2011-2018. 10.1200/JCO.2003.08.132.CrossRefPubMed Kager L, Zoubek A, Potschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jurgens H, Gadner H, Bielack SS: Cooperative German-Austrian-Swiss Osteosarcoma Study Group. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2003, 21 (10): 2011-2018. 10.1200/JCO.2003.08.132.CrossRefPubMed
16.
go back to reference Bacci G, Ferrari S, Bertoni F, Ruggieri P, Picci P, Longhi A, Casadei R, Fabbri N, Forni C, Versari M, Campanacci M: Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol. 2000, 18 (24): 4016-4027.PubMed Bacci G, Ferrari S, Bertoni F, Ruggieri P, Picci P, Longhi A, Casadei R, Fabbri N, Forni C, Versari M, Campanacci M: Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol. 2000, 18 (24): 4016-4027.PubMed
17.
go back to reference Fuchs N, Bielack SS, Epler D, Bieling P, Delling G, Korholz D, Graf N, Heise U, Jurgens H, Kotz R, Salzer-Kuntschik M, Weinel P, Werner M, Winkler K: Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol. 1998, 9 (8): 893-899. 10.1023/A:1008391103132.CrossRefPubMed Fuchs N, Bielack SS, Epler D, Bieling P, Delling G, Korholz D, Graf N, Heise U, Jurgens H, Kotz R, Salzer-Kuntschik M, Weinel P, Werner M, Winkler K: Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol. 1998, 9 (8): 893-899. 10.1023/A:1008391103132.CrossRefPubMed
18.
go back to reference Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ, Huvos AG, Betcher DL, Baum ES, Kisker CT, Miser JS: Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol. 1997, 15 (1): 76-84.PubMed Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ, Huvos AG, Betcher DL, Baum ES, Kisker CT, Miser JS: Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol. 1997, 15 (1): 76-84.PubMed
19.
go back to reference Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, Applewhite A, Vlamis V, Rosen G: Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol. 1992, 10 (1): 5-15.PubMed Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, Applewhite A, Vlamis V, Rosen G: Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol. 1992, 10 (1): 5-15.PubMed
20.
go back to reference Bacci G, Longhi A, Ferrari S, Lari S, Manfrini M, Donati D, Forni C, Versari M: Prognostic significance of serum alkaline phosphatase in osteosarcoma of the extremity treated with neoadjuvant chemotherapy: recent experience at Rizzoli Institute. Oncol Rep. 2002, 9 (1): 171-175.PubMed Bacci G, Longhi A, Ferrari S, Lari S, Manfrini M, Donati D, Forni C, Versari M: Prognostic significance of serum alkaline phosphatase in osteosarcoma of the extremity treated with neoadjuvant chemotherapy: recent experience at Rizzoli Institute. Oncol Rep. 2002, 9 (1): 171-175.PubMed
Metadata
Title
Osteosarcoma (Osteogenic sarcoma)
Author
Piero Picci
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2007
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/1750-1172-2-6

Other articles of this Issue 1/2007

Orphanet Journal of Rare Diseases 1/2007 Go to the issue